Skip to main content
logo
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
41.15
+0.70 (1.73%)
Jul 3, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Therapeutics
182.95M
Log In
Log In
Log In
Therapeutics Growth
948.62%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
United States
182.95M
Log In
Log In
Log In
United States Growth
948.62%
Log In
Log In
Log In